Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

THYROCARE TECHNOLOGIES Gains 4%; BSE HEALTHCARE Index Down 0.0%
Tue, 2 Jul 9:36

THYROCARE TECHNOLOGIES Gains 4%; BSE HEALTHCARE Index Down 0.0%Image source: asbe/www.istockphoto.com

THYROCARE TECHNOLOGIES share price has zoomed 4% and is presently trading at Rs 668.4.

Meanwhile, the BSE HEALTHCARE index is at 37,235.8 .

Among the top gainers in the BSE HEALTHCARE index today are ALEMBIC PHARMA (up 2.0%) and J.B.Chemicals (up 1.8%).

MAX HEALTHCARE INSTITUTE (down 2.5%) and METROPOLIS HEALTHCARE (down 1.4%) are among the top losers today.

Over the last one year, THYROCARE TECHNOLOGIES has moved up from Rs 522.1 to Rs 668.4, registering a gain of Rs 146.4 (up 28.0%).

On the other hand, the BSE HEALTHCARE index has moved up from 25,634.3 to 37,235.8, registering a gain of 45.3% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Glenmark Pharma (up 86.5%), Cadila Healthcare (up 83.5%) and CAPLIN POINT (up 83.3%).

Dear Reader: If You Invest in Midcap Stocks, this is for You

What About the Benchmark Indices?

The BSE Sensex is at 79,501.6 .

The top gainers among the BSE Sensex today are Infosys (up 1.2%) and HCl Tech. (up 0.9%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 24,133.3 . HDFC LIFE INSURANCE and Tata Motors are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 63,915.4 to 79,501.6, registering a gain of 15,586.2 points (up 24.4%).

THYROCARE TECHNOLOGIES Financial Update...

THYROCARE TECHNOLOGIES net profit grew 43.0% YoY to Rs 174 million for the quarter ended March 2024, compared to a profit of Rs 122 million a year ago. Net sales rose 13.5% to Rs 1,543 million during the period as against Rs 1,359 million in January-March 2023.

For the year ended March 2023, THYROCARE TECHNOLOGIES reported 63.5% decrease in net profit to Rs 644 million compared to net profit of Rs 1,761 million during FY22. Revenue of the company fell 10.6% to Rs 5,267 million during FY23.

The current Price to earnings ratio of THYROCARE TECHNOLOGIES, based on rolling 12 month earnings, stands at 51.2.


Equitymaster requests your view! Post a comment on "THYROCARE TECHNOLOGIES Gains 4%; BSE HEALTHCARE Index Down 0.0%". Click here!